UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Genome-Wide Identification and Expression Pattern Analysis of the WNK Gene Family in Apple under Abiotic Stress and Colletotrichum siamense Infection

International journal of molecular sciences, 2024-08, Vol.25 (15), p.8528

2024

Volltextzugriff (PDF)

Soil organic matter on arid saline-alkali land drives greenhouse gas emissions from artificial and natural grasslands in different directions

Frontiers in environmental science, 2024-01, Vol.12

2024

Volltextzugriff (PDF)

Construction of pseudorabies virus variant attenuated vaccine: codon deoptimization of US3 and UL56 genes based on PRV gE/TK deletion strain

Frontiers in microbiology, 2023-10, Vol.14, p.1248573-1248573

2023

Volltextzugriff (PDF)

Research on the Current Situation and Future Development Trend of Immersive Virtual Reality in the Field of Education

Sustainability, 2023-05, Vol.15 (9), p.7531

2023

Volltextzugriff (PDF)

Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer Term Follow-Up from the Phase 3 KEYNOTE-240 Trial

Liver cancer (Basel ), 2023-09, Vol.12 (4), p.309-320

2023

Volltextzugriff (PDF)

ALBI score and outcomes in patients with hepatocellular carcinoma: post hoc analysis of the randomized controlled trial KEYNOTE-240

Therapeutic advances in medical oncology, 2021, Vol.13, p.17588359211039928-17588359211039928

2021

Volltextzugriff (PDF)

Abstract CT075: KEYNOTE-189: Randomized, double-blind, phase 3 study of pembrolizumab (pembro) or placebo plus pemetrexed (pem) and platinum as first-line therapy for metastatic NSCLC

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.CT075-CT075

2018

Volltextzugriff (PDF)

Topology and Modulation of Fractional-Level MMC for DC Distribution Grids

IEEE transactions on industry applications, 2023-05, Vol.59 (3), p.3615-3626

2023

Volltextzugriff (PDF)

A Real-time Visual SLAM towards Dynamic Scenes Based on YOLACT

2024 43rd Chinese Control Conference (CCC), 2024, p.8008-8013

2024

Volltextzugriff (PDF)

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

The New England journal of medicine, 2018-05, Vol.378 (22), p.2078-2092

2018

Volltextzugriff (PDF)

MiR-142-3p inhibits adipogenic differentiation and autophagy in obesity through targeting KLF9

Molecular and cellular endocrinology, 2020-12, Vol.518, p.111028-111028, Article 111028

2020

Volltextzugriff (PDF)

A model that predicts a real-time tumour surface using intra-treatment skin surface and end-of-expiration and end-of-inhalation planning CT images

British journal of radiology, 2024-05, Vol.97 (1157), p.980-992

2024

Volltextzugriff (PDF)

Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma

European journal of cancer (1990), 2017-11, Vol.86, p.37-45

2017

Volltextzugriff (PDF)

Research on optimization algorithm of Pedestrian Dead Reckoning based on Kalman filter

2024 43rd Chinese Control Conference (CCC), 2024, p.6217-6222

2024

Volltextzugriff (PDF)

Feasibility evaluation of radiotherapy positioning system guided by augmented reality and point cloud registration

Journal of applied clinical medical physics, 2024-04, Vol.25 (4), p.e14243-n/a

2024

Volltextzugriff (PDF)

Effective doses of midazolam oral solution for the prevention of preoperative anxiety in paediatric patients

International journal of paediatric dentistry, 2024-09, Vol.34 (5), p.621-629

2024

Volltextzugriff (PDF)

光学变色油墨的颜色测量方法研究

Guangxué xuébào, 2023, Vol.43 (22), p.2212003

2023

Volltextzugriff (PDF)

Pembrolizumab (pembro) versus placebo (pbo) in patients (pts) with advanced hepatocellular carcinoma (aHCC) previously treated with sorafenib: Updated data from the randomized, phase 3 KEYNOTE-240 study

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.4072-4072

2021

Volltextzugriff (PDF)

Pembrolizumab (pembro) vs placebo (pbo) in patients (pts) with advanced hepatocellular carcinoma (aHCC) previously treated with sorafenib: Updated data from the randomized, phase III KEYNOTE-240 study

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.268-268

2021

Volltextzugriff (PDF)

Nonparametric Bayesian functional clustering for time-course microarray data

Statistics and its interface, 2014, Vol.7 (4), p.543-557

2014

Volltextzugriff (PDF)

A randomized, double-blind, non-inferiority trial evaluating the efficacy and safety of omarigliptin, a once-weekly DPP-4 inhibitor, or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy

Current medical research and opinion, 2017-10, Vol.33 (10), p.1861-1868

2017

Volltextzugriff (PDF)

Use of Prohibited Medication, a Potentially Overlooked Confounder in Clinical Trials: Omarigliptin (Once-weekly DPP-4 Inhibitor) Monotherapy Trial in 18- to 45-year-olds

Clinical therapeutics, 2017-10, Vol.39 (10), p.2024-2037

2017

Volltextzugriff (PDF)

P2-14-57 (B). 1L Pembrolizumab+Carbo+Taxane With / Without Maintenance Olaparib in Squamous NSCLC : KEYLYNK-008

Japanese Journal of Lung Cancer, 2020-10, Vol.60 (6), p.709-709

2020

Volltextzugriff (PDF)

ALBI score and outcomes in patients with hepatocellular carcinoma: analysis of the randomized controlled trial KEYNOTE-240

Therapeutic advances in medical oncology, 2021-09, Vol.13

2021

Volltextzugriff (PDF)

1 – 25 von 558

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(478)
Mit Volltextzugriff
(496)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(432)
Life Sciences & Biomedicine
(232)
Technology
(153)
Physical Sciences
(144)
Chemistry
(74)
Humans
(73)
Engineering
(70)
Materials Science
(61)
Materials Science, Multidisciplinary
(49)
Science & Technology - Other Topics
(46)
Physics
(40)
Animals
(37)
Male
(33)
Chemistry, Physical
(31)
Female
(30)
Pharmacology & Pharmacy
(30)
Physics, Applied
(30)
Engineering, Electrical & Electronic
(28)
Chemistry, Multidisciplinary
(27)
Oncology
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Ssrn Electronic Journal
(6)
Acs Nano
(5)
Plos One
(5)
Water Research
(5)
Angewandte Chemie
(4)
Bioresource Technology
(4)
Carbon
(4)
Cell Death & Disease
(4)
Journal Of Agricultural And Food Chemistry
(4)
Journal Of Ethnopharmacology
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Genome-Wide Identification and Expression Pattern Analysis of the WNK Gene Family in Apple under Abiotic Stress and Colletotrichum siamense Infection

Soil organic matter on arid saline-alkali land drives greenhouse gas emissions from artificial and natural grasslands in different directions

Construction of pseudorabies virus variant attenuated vaccine: codon deoptimization of US3 and UL56 genes based on PRV gE/TK deletion strain

Research on the Current Situation and Future Development Trend of Immersive Virtual Reality in the Field of Education

Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer Term Follow-Up from the Phase 3 KEYNOTE-240 Trial

ALBI score and outcomes in patients with hepatocellular carcinoma: post hoc analysis of the randomized controlled trial KEYNOTE-240

Abstract CT075: KEYNOTE-189: Randomized, double-blind, phase 3 study of pembrolizumab (pembro) or placebo plus pemetrexed (pem) and platinum as first-line therapy for metastatic NSCLC

Topology and Modulation of Fractional-Level MMC for DC Distribution Grids

A Real-time Visual SLAM towards Dynamic Scenes Based on YOLACT

Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

MiR-142-3p inhibits adipogenic differentiation and autophagy in obesity through targeting KLF9

A model that predicts a real-time tumour surface using intra-treatment skin surface and end-of-expiration and end-of-inhalation planning CT images

Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma

Research on optimization algorithm of Pedestrian Dead Reckoning based on Kalman filter

Feasibility evaluation of radiotherapy positioning system guided by augmented reality and point cloud registration

Effective doses of midazolam oral solution for the prevention of preoperative anxiety in paediatric patients

光学变色油墨的颜色测量方法研究

Pembrolizumab (pembro) versus placebo (pbo) in patients (pts) with advanced hepatocellular carcinoma (aHCC) previously treated with sorafenib: Updated data from the randomized, phase 3 KEYNOTE-240 study

Pembrolizumab (pembro) vs placebo (pbo) in patients (pts) with advanced hepatocellular carcinoma (aHCC) previously treated with sorafenib: Updated data from the randomized, phase III KEYNOTE-240 study

Nonparametric Bayesian functional clustering for time-course microarray data

A randomized, double-blind, non-inferiority trial evaluating the efficacy and safety of omarigliptin, a once-weekly DPP-4 inhibitor, or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy

Use of Prohibited Medication, a Potentially Overlooked Confounder in Clinical Trials: Omarigliptin (Once-weekly DPP-4 Inhibitor) Monotherapy Trial in 18- to 45-year-olds

P2-14-57 (B). 1L Pembrolizumab+Carbo+Taxane With / Without Maintenance Olaparib in Squamous NSCLC : KEYLYNK-008

ALBI score and outcomes in patients with hepatocellular carcinoma: analysis of the randomized controlled trial KEYNOTE-240

Suchergebnisse filtern